Serum type III procollagen peptide as a non-invasive marker of liver damage during infancy and childhood in extrahepatic biliary atresia, idiopathic hepatitis of infancy and α1 antitrypsin deficiency

This publication has 11 references indexed in Scilit:

• Hepatitis syndrome in infancy--an epidemiological survey with 10 year follow up.
  Archives of Disease in Childhood, 1985
• Serum Type Iii Procollagen Peptide in Alcoholic Liver Disease and Idiopathic Hemochromatosis: Its Relationship to Hepatic Fibrosis, Activity of the Disease and Iron Overload
  Hepatology, 1985
• Variation in serum Type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis*
  European Journal of Clinical Investigation, 1985
• Blood analysis for liver fibrosis
  Journal of Hepatology, 1985
• Long-Term Follow-Up of Serum N-Terminal Propeptide of Collagen Type III Levels in Patients with Chronic Liver Disease†
  Hepatology, 1984
• The N-Terminal Propeptide of Collagen Type III in Serum Reflects Activity and Degree of Fibrosis in Patients with Chronic Liver Disease†
  Hepatology, 1984
• Hepatic Peptidyl Prolyl Hydroxylase Activity and Liver Fibrosis-A Prospective Study of 94 Infants and Children with Hepatobiliary Disorders
  Hepatology, 1984
• Heterogeneity of the antigens related to the aminoterminal propeptide of type III procollagen in human serum
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1982
• Serum concentration of procollagen-III-peptide in comparison with the serum activity of N-acetyl-β-glucosaminidase for diagnosis of the activity of liver fibrosis in patients with chronic active liver diseases
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1981
• Radioimmunoassay for type III procollagen peptide and its application to human liver disease
  European Journal of Clinical Investigation, 1979